• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性卵巢癌的早期检测

Early detection of familial ovarian cancer.

作者信息

Dørum A, Kristensen G B, Abeler V M, Tropé C G, Møller P

机构信息

Unit of Medical Genetics, Norwegian Radium Hospital, Oslo, Norway.

出版信息

Eur J Cancer. 1996 Sep;32A(10):1645-51. doi: 10.1016/0959-8049(96)00137-2.

DOI:10.1016/0959-8049(96)00137-2
PMID:8983269
Abstract

When ovarian cancer is detected at an early stage, prognosis is good, which has led to discussion of a screening programme. The aim of this study was to identify and examine women at high risk of familial ovarian cancer, and to evaluate the inclusion criteria and the diagnostic methods for early detection of ovarian cancer. We report the first round screening findings in a prospective study of 180 women (mean age 43.4 years) considered to be at high risk of ovarian cancer based on family history. They were subjected to gynaecological examination with transvaginal ultrasound (TVU), CA125 and breast examination. Of these, 13 women with oestrogen receptor positive breast cancer had therapeutic oophorectomy and the ovaries were histologically examined. Among 180 women examined, nine ovarian cancers (among them two found at oophorectomy because of breast cancer) (mean age 49.0 years), seven benign tumours of the ovary (mean age 48.1 years), one cancer of the cervix, and four breast cancers were diagnosed. The prevalence of ovarian cancers (5%) was significantly more than in any previous series. TVU as a diagnostic method proved useful and detected 7/9 cancers, whereas CA125 was elevated in 4/9 cancers. To our knowledge, this is the first programme which has successfully delineated a high risk group and prospectively demonstrated their high prevalence of ovarian cancer. Possible biases are discussed.

摘要

卵巢癌若在早期被发现,预后良好,这引发了对筛查项目的讨论。本研究的目的是识别和检查有家族性卵巢癌高风险的女性,并评估早期检测卵巢癌的纳入标准和诊断方法。我们报告了一项前瞻性研究的首轮筛查结果,该研究针对180名(平均年龄43.4岁)基于家族史被认为有卵巢癌高风险的女性。她们接受了经阴道超声(TVU)妇科检查、CA125检测和乳房检查。其中,13名雌激素受体阳性乳腺癌女性接受了治疗性卵巢切除术,并对卵巢进行了组织学检查。在接受检查的180名女性中,诊断出9例卵巢癌(其中2例因乳腺癌在卵巢切除术中发现)(平均年龄49.0岁)、7例卵巢良性肿瘤(平均年龄48.1岁)、1例宫颈癌和4例乳腺癌。卵巢癌的患病率(5%)显著高于以往任何系列研究。TVU作为一种诊断方法被证明是有用的,检测出了7/9的癌症,而4/9的癌症患者CA125升高。据我们所知,这是首个成功界定高风险组并前瞻性证明其卵巢癌高患病率的项目。文中讨论了可能存在的偏差。

相似文献

1
Early detection of familial ovarian cancer.家族性卵巢癌的早期检测
Eur J Cancer. 1996 Sep;32A(10):1645-51. doi: 10.1016/0959-8049(96)00137-2.
2
Prospectively detected cancer in familial breast/ovarian cancer screening.在家族性乳腺癌/卵巢癌筛查中前瞻性检测到的癌症
Acta Obstet Gynecol Scand. 1999 Nov;78(10):906-11.
3
CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.对高危女性进行CA125检测和经阴道超声监测并不能预防晚期卵巢癌的诊断。
Gynecol Oncol. 2006 Jan;100(1):20-6. doi: 10.1016/j.ygyno.2005.08.038. Epub 2005 Sep 26.
4
Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.寻求乳腺癌和卵巢癌遗传癌症风险评估的女性的癌症筛查及降低风险行为。
Oncol Nurs Forum. 2006 Nov 3;33(2):E27-35. doi: 10.1188/06.ONF.E27-E35.
5
Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.基于超声的家族性卵巢癌筛查诊所的结果:一项10年观察性研究。
Ultrasound Obstet Gynecol. 2003 Apr;21(4):378-85. doi: 10.1002/uog.65.
6
Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.超声作为二线检测在卵巢癌筛查中对血清 CA125 的性能评估。
BJOG. 2014 Dec;121 Suppl 7:35-9. doi: 10.1111/1471-0528.13211.
7
[Familial ovarian carcinoma].[家族性卵巢癌]
Wien Med Wochenschr. 1996;146(1-2):10-3.
8
Familial ovarian cancer screening.
Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):321-38. doi: 10.1016/j.bpobgyn.2005.10.017. Epub 2005 Dec 20.
9
Ovarian cancer screening in women with a family history of breast or ovarian cancer.对有乳腺癌或卵巢癌家族史的女性进行卵巢癌筛查。
Obstet Gynecol. 2006 Nov;108(5):1176-84. doi: 10.1097/01.AOG.0000239105.39149.d8.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer.利用碳量子点进行光学生物传感以评估癌抗原125用于卵巢癌的早期诊断
RSC Adv. 2021 Sep 20;11(49):31047-31057. doi: 10.1039/d1ra05121k. eCollection 2021 Sep 14.
2
Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms.肿瘤坏死因子-α和白细胞介素-10在良性和恶性卵巢肿瘤中的免疫组织化学染色
Oncol Lett. 2015 Feb;9(2):979-983. doi: 10.3892/ol.2014.2781. Epub 2014 Dec 8.
3
CA125 in ovarian cancer.
卵巢癌中的CA125
Biomark Med. 2007 Dec;1(4):513-23. doi: 10.2217/17520363.1.4.513.
4
Screening behavior in women at increased familial risk for breast cancer.乳腺癌家族风险增加的女性的筛查行为。
Fam Cancer. 2006;5(4):359-68. doi: 10.1007/s10689-006-0006-8. Epub 2006 Jul 7.
5
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.开发一种CA125-间皮素细胞黏附测定法作为生物制剂发现的筛选工具。
Cancer Lett. 2007 Mar 8;247(1):130-6. doi: 10.1016/j.canlet.2006.03.029. Epub 2006 May 4.
6
Bead-based ELISA for validation of ovarian cancer early detection markers.基于微珠的酶联免疫吸附测定法用于验证卵巢癌早期检测标志物
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2117-24. doi: 10.1158/1078-0432.CCR-05-2007.